|
STK38L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.258020E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.963300E-03 |
| Normal-vs-Stage2 |
1.004880E-04 |
| Normal-vs-Stage3 |
8.061400E-03 |
| Normal-vs-Stage4 |
2.69750000003732E-06 |
| Stage1-vs-Stage2 |
2.924400E-02 |
| Stage1-vs-Stage3 |
5.915400E-01 |
| Stage1-vs-Stage4 |
3.299900E-03 |
| Stage2-vs-Stage3 |
2.197000E-01 |
| Stage2-vs-Stage4 |
3.312600E-01 |
| Stage3-vs-Stage4 |
3.819900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.857000E-03 |
| Normal-vs-AfricanAmerican |
9.563700E-02 |
| Normal-vs-Asian |
7.574400E-02 |
| Caucasian-vs-AfricanAmerican |
7.159400E-01 |
| Caucasian-vs-Asian |
5.258200E-01 |
| AfricanAmerican-vs-Asian |
9.182800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.418400E-03 |
| Normal-vs-Female |
1.361930E-03 |
| Male-vs-Female |
9.316000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.286000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.62690000000377E-05 |
| Normal-vs-Age(61-80Yrs) |
5.373500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.546800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.179820E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.795920E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.603400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.698000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.761200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.292000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.959200E-01 |
| Classical-VS-Follicular |
4.188100E-04 |
| Classical-VS-Other |
5.897000E-01 |
| Classical-VS-Normal |
2.537500E-02 |
| Tall-VS-Follicular |
5.241000E-01 |
| Tall-VS-Other |
9.049600E-01 |
| Tall-VS-Normal |
3.189700E-02 |
| Follicular-VS-Other |
5.120600E-01 |
| Follicular-VS-Normal |
2.71679999996888E-06 |
| Other-VS-Normal |
1.470420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.00090000004971E-06 |
| Normal-vs-N1 |
9.182600E-03 |
| N0-vs-N1 |
3.152600E-01 |
|
|
